Merck (MRK) reachead $117.17 at the closing of the latest trading day, reflecting a -0.05% change compared to its last close.

Merck ’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value.

A letter from the FDA rejecting Merck Sharpe & Dohme Corp.'s proposed label warning that its osteoporosis drug Fosamax could cause stress fractures doesn’t preempt state law claims alleging the ...

The Pan American Health Organisation has launched a partnership with Merck & Company to improve health care and maternal health outcomes for women ...

Pharma giant Merck applies the technology to streamline IT operations. Such examples speak of the versatility of the software. Furthermore, these successes have made the Now platform a favorite among ...

The major European markets are down in negative territory on Friday with investors assessing the likely impact of the monetary policy ...

RedChip Companies will air interviews with Nova Minerals Limited and Soligenix Inc. on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, September 21, ...

FN Media Group News Commentary - Breast cancer is an illness in which the breast cells get uncontrollably large. The type of breast cancer depends on which cells in the breast become cancerous. Cancer ...

The US stock markets opened lower on Friday, September 20, as investors held back after a jump in the previous session, which ...

Shares of Bicara Therapeutics—a biopharmaceutical company backed by Indian billionaire Kiran Mazumdar-Shaw—surged about 42% ...

Merck (NYSE: MRK), known as MSD outside of the United States ... which occurs in many cardiovascular diseases that can lead to heart dysfunction and failure. The Company plans on releasing new data ...

One simple Vanguard ETF, the Vanguard High Dividend Yield ETF ( VYM -0.17%), has the potential to turn a consistent ...